Home LiteratureArticle Details
PMID: 10564139 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Inhaled nitric oxide inhibits NOS activity in lambs: potential mechanism for rebound pulmonary hypertension.

The American journal of physiology ·Vol. 277 ·No. 5 ·1999-00-00 ·Pages H1849-56

Black SM, Heidersbach RS, McMullan DM, Bekker JM, Johengen MJ, Fineman JR

Abstract

Life-threatening increases in pulmonary vascular resistance have been noted on acute withdrawal of inhaled nitric oxide (NO), although the mechanisms remain unknown. In vitro data suggest that exogenous NO exposure inhibits endothelial NO synthase (NOS) activity. Thus the objectives of this study were to determine the effects of inhaled NO therapy and its acute withdrawal on endogenous NOS activity and gene expression in vivo in the intact lamb. Six 1-mo-old lambs were mechanically ventilated and instrumented to measure vascular pressures and left pulmonary blood flow. Inhaled NO (40 ppm) acutely decreased left pulmonary vascular resistance by 27. 5 +/- 4.7% (P < 0.05). This was associated with a 207% increase in plasma cGMP concentrations (P < 0.05). After 6 h of inhaled NO, NOS activity was reduced to 44.3 +/- 5.9% of pre-NO values (P < 0.05). After acute withdrawal of NO, pulmonary vascular resistance increased by 52.1 +/- 11.6% (P < 0.05) and cGMP concentrations decreased. Both returned to pre-NO values within 60 min. One hour after NO withdrawal, NOS activity increased by 48.4 +/- 19.1% to 70% of pre-NO values (P < 0.05). Western blot analysis revealed that endothelial NOS protein levels remained unchanged throughout the study period. These data suggest a role for decreased endogenous NOS activity in the rebound pulmonary hypertension noted after acute withdrawal of inhaled NO.

MeSH Terms
Administration, Inhalation Animals Cyclic GMP/blood Endothelium, Vascular/enzymology Enzyme Inhibitors/administration & dosage,adverse effects,pharmacology Gene Expression/drug effects Hypertension, Pulmonary/chemically induced Nitric Oxide/administration & dosage,adverse effects,pharmacology Nitric Oxide Synthase/antagonists & inhibitors,genetics,metabolism Pulmonary Circulation/drug effects Sheep Substance Withdrawal Syndrome Time Factors Vascular Resistance/drug effects
Chemicals
Enzyme Inhibitors Nitric Oxide Nitric Oxide Synthase Cyclic GMP
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Black S M
Department of Pediatrics, Northwestern University Medical School, Chicago, Illinois 60611-3008, USA. [email protected]
Heidersbach R S
McMullan D M
Bekker J M
Johengen M J
Fineman J R
Article Info
Journal
The American journal of physiology
Abbr.
Am J Physiol
ISSN
0002-9513
Published
1999-00-00
Pages
H1849-56
Language
English
Region
United States
NLM ID
0370511
Subset
IM
Grants
NHLBI NIH HHS · HL-60190 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]